283 related articles for article (PubMed ID: 23084969)
1. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Racil Z; Weinbergerova B; Kocmanova I; Muzik J; Kouba M; Drgona L; Masarova L; Guman T; Tothova E; Forsterova K; Haber J; Ziakova B; Bojtarova E; Vydra J; Mudry P; Foralova R; Sejnova D; Mallatova N; Kandrnal V; Cetkovsky P; Mayer J
Int J Infect Dis; 2013 Feb; 17(2):e101-9. PubMed ID: 23084969
[TBL] [Abstract][Full Text] [Related]
2. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
3. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
[TBL] [Abstract][Full Text] [Related]
4. [Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy].
Rácil Z; Mayer J; Kocmanová I; Wagnerová B; Winterová J; Folber F; Lengerová M; Moulis M; Zácková D; Smardová L; Janíková A; Navrátil M; Dvoráková D; Vorlícek J
Vnitr Lek; 2008 Feb; 54(2):157-68. PubMed ID: 23687707
[TBL] [Abstract][Full Text] [Related]
5. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
[TBL] [Abstract][Full Text] [Related]
6. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
8. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
9. Invasive aspergillosis in a paediatric haematology department: a 15-year review.
Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746
[TBL] [Abstract][Full Text] [Related]
10. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
Xie LP; Liu T; Meng WT; Zhou J
Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
[TBL] [Abstract][Full Text] [Related]
12. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
[TBL] [Abstract][Full Text] [Related]
13. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
[TBL] [Abstract][Full Text] [Related]
14. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
15. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Meyer M; Waldvogel S; Chalandon Y; Bongiovanni M; Pache JC; Van Delden C
Scand J Infect Dis; 2007; 39(8):731-3. PubMed ID: 17654353
[TBL] [Abstract][Full Text] [Related]
17. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases.
Yoo JH; Choi JH; Choi SM; Lee DG; Shin WS; Min WS; Kim CC
Clin Infect Dis; 2005 Feb; 40(3):392-8. PubMed ID: 15668862
[TBL] [Abstract][Full Text] [Related]
18. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
19. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.
Millon L; Piarroux R; Deconinck E; Bulabois CE; Grenouillet F; Rohrlich P; Costa JM; Bretagne S
J Clin Microbiol; 2005 Oct; 43(10):5097-101. PubMed ID: 16207969
[TBL] [Abstract][Full Text] [Related]
20. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]